Antimicrobial Agents Practice Questions

Q: What is the recommended adult prophylaxis for meningococcal infection?

Rifampicin 600 mg twice daily for 2 days. **Explanation:** The primary goal of prophylaxis in meningococcal infection is to eradicate the nasopharyngeal carriage of *Neisseria meningitidis*, thereby preventing secondary cases among close contacts. **Why Rifampicin is the Correct Choice:** Rifampicin is the drug of choice for chemoprophylaxis because it achieves high concentrations in salivary and respiratory secretions, effectively eliminating the carrier state. The standard adult regimen is **600 mg twice daily for 2 days** (total of 4 doses). For children, the dose is 10 mg/kg. **Analysis of Incorrect Options:** * **B, C, and D (Ampicillin, Tetracycline, Chloramphenicol):** While these antibiotics are effective in treating active clinical disease (meningitis or meningococcemia) because they cross the blood-brain barrier, they are **ineffective at eradicating the nasopharyngeal carrier state**. They do not reach sufficient concentrations in mucosal secretions to eliminate the bacteria from the throat. **High-Yield Clinical Pearls for NEET-PG:** * **Alternative Agents:** If Rifampicin is contraindicated (e.g., pregnancy), a single dose of **Ciprofloxacin (500 mg)** or a single IM injection of **Ceftriaxone (250 mg)** are recommended alternatives. * **Timing:** Prophylaxis should be administered as soon as possible, ideally within 24 hours of identifying the index case. It is generally not recommended if more than 14 days have passed. * **Target Group:** Prophylaxis is meant for "close contacts" (household members, daycare contacts, or healthcare workers exposed to respiratory secretions), not for casual contacts. * **Side Effect Note:** Warn patients that Rifampicin may turn urine and secretions orange.

Q: Cobicistat is used along with which of the following antiretroviral drugs?

Darunavir. **Cobicistat** is a potent inhibitor of the cytochrome P450 enzyme **CYP3A4**. It does not possess any intrinsic antiviral activity; instead, it acts as a **pharmacokinetic enhancer** (a "booster"). By inhibiting the metabolism of co-administered drugs, it increases their plasma concentrations, allowing for lower doses and improved patient compliance [1]. 1. **Why Darunavir is correct:** Darunavir is a Protease Inhibitor (PI) that is extensively metabolized by CYP3A4. To achieve therapeutic levels, it must be "boosted." Cobicistat is FDA-approved for use with **Darunavir** (and Atazanavir) to enhance its efficacy. This combination is frequently used in fixed-dose combinations (e.g., Prezcobix) [1]. 2. **Why other options are incorrect:** * **Ritonavir:** This is itself a potent CYP3A4 inhibitor and the original "booster" drug. It is used to boost other PIs, but it is not boosted by Cobicistat [1]. * **Indinavir and Saquinavir:** These are older Protease Inhibitors. While they can be boosted by Ritonavir, they are rarely used in modern clinical practice and are not the standard partners for Cobicistat in current therapeutic guidelines [1]. **Clinical Pearls for NEET-PG:** * **Cobicistat vs. Ritonavir:** Unlike Ritonavir, Cobicistat has **no induction effect** on other enzymes and lacks antiviral activity, leading to fewer drug-drug interactions and side effects. * **Renal Caution:** Cobicistat can cause a functional (but harmless) increase in **serum creatinine** by inhibiting tubular secretion without affecting actual GFR. * **Elvitegravir:** Cobicistat is also a key component of the "Stribild" and "Genvoya" regimens, where it boosts the Integrase Inhibitor Elvitegravir.

Q: An inhibitor of bacterial protein synthesis with a narrow spectrum of antibacterial activity has been used in the management of abdominal abscess caused by Bacteroides fragilis, though antibiotic-associated colitis has occurred. Which of the following drugs is being described?

Clindamycin. ### Explanation The correct answer is **Clindamycin**. **1. Why Clindamycin is correct:** Clindamycin is a **Lincosamide** antibiotic that inhibits bacterial protein synthesis by binding to the **50S ribosomal subunit**. It has a relatively narrow spectrum, primarily targeting **Gram-positive cocci** (including MRSA) and **anaerobes**. It is the drug of choice for anaerobic infections above the diaphragm, but it is also highly effective against abdominal anaerobes like ***Bacteroides fragilis***. A classic, high-yield adverse effect of Clindamycin is **Antibiotic-Associated Pseudomembranous Colitis**, caused by the overgrowth of *Clostridioides difficile* due to the suppression of normal gut flora. **2. Why the other options are incorrect:** * **Clarithromycin:** A Macrolide used primarily for respiratory tract infections (*H. influenzae*, *M. pneumoniae*) and *H. pylori* eradication. It does not have significant activity against *B. fragilis*. * **Minocycline:** A Tetracycline used for acne or MRSA. While it inhibits protein synthesis (30S subunit), it is not the preferred agent for deep-seated anaerobic abscesses and is less commonly associated with *C. difficile* than Clindamycin. * **Ticarcillin:** An antipseudomonal penicillin. It inhibits **cell wall synthesis** (not protein synthesis) and has a broad spectrum of activity. **3. NEET-PG High-Yield Pearls:** * **Mechanism:** Same as Macrolides and Chloramphenicol (50S inhibition). * **Clinical Rule:** "Anaerobes above the diaphragm = Clindamycin; Anaerobes below the diaphragm = Metronidazole" (though Clindamycin is active against both). * **C. difficile Treatment:** If Clindamycin causes colitis, the treatment of choice is **Oral Vancomycin** or **Fidaxomicin** (Metronidazole is now second-line). * **Resistance:** Cross-resistance occurs between Macrolides and Clindamycin via **MLSB resistance** (methylation of the 23S rRNA).

Q: Which of the following is not an indication for cotrimoxazole?

Chancroid. **Explanation:** Cotrimoxazole is a fixed-dose combination of **Sulfamethoxazole** and **Trimethoprim** (5:1 ratio) that acts via sequential blockade of folate synthesis. While it was once a broad-spectrum mainstay, increasing resistance has altered its clinical utility. **Why Chancroid is the correct answer:** Chancroid is caused by *Haemophilus ducreyi*. According to current CDC and WHO guidelines, the first-line treatment for Chancroid is **Azithromycin (1g orally, single dose)** or **Ceftriaxone (250mg IM)**. Cotrimoxazole is no longer recommended for Chancroid due to widespread resistance and the availability of more effective single-dose regimens. **Analysis of Incorrect Options:** * **Lower UTI:** Cotrimoxazole remains an effective option for uncomplicated UTIs caused by sensitive strains of *E. coli*, though it is often reserved for cases where first-line agents like Nitrofurantoin are contraindicated. * **Prostatitis:** Trimethoprim is highly lipid-soluble and achieves excellent penetration into prostatic fluid, making cotrimoxazole a valid choice for bacterial prostatitis. * **Typhoid Fever:** Although Fluoroquinolones and Ceftriaxone are now preferred due to MDR (Multi-Drug Resistant) *Salmonella typhi*, cotrimoxazole is still considered an alternative indication in sensitive cases. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Cotrimoxazole is the DOC for ***Pneumocystis jirovecii* pneumonia** (both prophylaxis and treatment) and ***Nocardiosis***. * **Adverse Effects:** Watch for **Stevens-Johnson Syndrome (SJS)**, crystalluria (sulfonamide component), and megaloblastic anemia (trimethoprim component). * **Contraindication:** Avoid in pregnancy (folate antagonism) and in patients with G6PD deficiency (risk of hemolysis).

Q: A 75-year-old male develops a cough producing blood-tinged sputum and a fever of 104°F. A sputum smear reveals Gram-positive cocci in clusters, and a chest x-ray shows increased density in the right upper lobe. Which of the following penicillins is most likely to be ineffective against this patient's likely pathogen?

Ticarcillin. **Explanation:** **1. Analysis of the Clinical Scenario:** The patient presents with symptoms of pneumonia (fever, cough, blood-tinged sputum). The key diagnostic clue is the sputum smear showing **Gram-positive cocci in clusters**, which is pathognomonic for ***Staphylococcus aureus***. Most community and hospital strains of *S. aureus* produce **penicillinase** (a type of $\beta$-lactamase), making them resistant to standard penicillins like Penicillin G and Aminopenicillins. **2. Why Ticarcillin is the Correct Answer:** **Ticarcillin** is a carboxypenicillin categorized as an **Antipseudomonal penicillin**. While it has excellent activity against Gram-negative rods (like *Pseudomonas aeruginosa*), it is **susceptible to degradation by staphylococcal penicillinase**. Therefore, it is ineffective against penicillinase-producing *S. aureus* unless combined with a $\beta$-lactamase inhibitor (e.g., Clavulanic acid). **3. Why the Other Options are Incorrect:** * **Oxacillin, Cloxacillin, and Nafcillin** belong to the class of **Antistaphylococcal penicillins**. These drugs possess bulky side chains that sterically hinder the action of staphylococcal $\beta$-lactamase. They are the drugs of choice for Methicillin-Sensitive *Staphylococcus aureus* (MSSA). **High-Yield Clinical Pearls for NEET-PG:** * **DOC for MSSA:** Nafcillin (IV) or Cloxacillin (Oral). * **MRSA Mechanism:** Resistance is due to an altered target site (**PBP-2a**), encoded by the ***mecA* gene**, not $\beta$-lactamase production. Therefore, even antistaphylococcal penicillins fail against MRSA. * **Antipseudomonal Penicillins:** Include Carboxypenicillins (Ticarcillin, Carbenicillin) and Ureidopenicillins (Piperacillin). Remember: "Piperacillin is the most potent among these."

Q: Which antimalarial agent(s) should be avoided in pregnancy?

Primaquine. The correct answer is **Primaquine**. **Why Primaquine is avoided:** Primaquine is strictly contraindicated throughout pregnancy [1]. The primary concern is that the drug can cross the placenta and reach the fetus. If the fetus is **Glucose-6-Phosphate Dehydrogenase (G6PD) deficient**, Primaquine can induce severe **fetal hemolysis**, leading to intrauterine anemia and potential fetal demise [1]. Since the G6PD status of a fetus cannot be safely determined in utero, the drug is withheld until after delivery. **Analysis of other options:** * **Chloroquine:** It is considered the drug of choice for sensitive *P. falciparum* and *P. vivax* during all trimesters of pregnancy [1]. It is safe and non-teratogenic. * **Quinine:** It is the mainstay of treatment for severe malaria or chloroquine-resistant malaria in the first trimester. While high doses can be oxytocic, therapeutic doses are safe. * **Anti-folates (e.g., Sulfadoxine-Pyrimethamine):** These are used for Intermittent Preventive Treatment (IPTp) in the second and third trimesters. **Tetracyclines** (Doxycycline) are indeed avoided in pregnancy due to effects on fetal bones and teeth [1], but since the question asks for the most definitive "antimalarial agent" (singular/primary focus) and Primaquine carries the specific risk of fetal hemolysis, Primaquine remains the most classic contraindication in this context. **NEET-PG High-Yield Pearls:** * **Tafenoquine**, like Primaquine, is also contraindicated in pregnancy due to G6PD-related hemolysis risks. * **Artemisinin-based Combination Therapy (ACT):** Now recommended by the WHO as first-line treatment for uncomplicated malaria in **all trimesters**, including the first. * **Radical Cure:** For *P. vivax* in pregnancy, treat the acute attack with Chloroquine and defer Primaquine (radical cure for hypnozoites) until after the mother has finished breastfeeding [1].

Q: Which of the following antibiotics has the maximum auditory toxicity?

Amikacin. ### Explanation Aminoglycosides are notorious for their dose-dependent and duration-dependent **ototoxicity**, which can manifest as either **vestibular damage** (balance issues) or **cochlear damage** (hearing loss). This toxicity occurs due to the accumulation of the drug in the perilymph and endolymph, leading to the destruction of sensory hair cells. **Why Amikacin is the correct answer:** While all aminoglycosides can cause both types of damage, they exhibit a preference for one over the other. **Amikacin** and **Kanamycin** are the most potent **cochleotoxic** agents in this class. Among the options provided, Amikacin is clinically recognized for having the **maximum auditory toxicity**, often leading to irreversible high-frequency hearing loss. **Analysis of Incorrect Options:** * **Streptomycin:** Primarily **vestibulotoxic**. It is more likely to cause vertigo and nystagmus than hearing loss. * **Kanamycin:** Highly cochleotoxic, but in modern clinical practice and standardized competitive exams, Amikacin is cited as having the highest potential for auditory damage. * **Tobramycin:** Similar to Gentamicin, it affects both systems but is predominantly **vestibulotoxic**. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Ototoxicity:** * **Cochleotoxic (Hearing):** **A**mikacin, **K**anamycin, **N**eomycin (Mnemonic: **AKN** - "A"uditory). * **Vestibulotoxic (Balance):** **S**treptomycin, **G**entamicin (Mnemonic: **SG** - "S"haking). * **Nephrotoxicity:** **Neomycin** is the most nephrotoxic (hence used only topically/orally), while **Streptomycin** is the least. * **Neuromuscular Blockade:** Aminoglycosides can worsen Myasthenia Gravis; **Neomycin** is the most potent blocker, while **Tobramycin** is the least. * **Monitoring:** Ototoxicity is often irreversible; therefore, baseline and periodic audiometry are recommended during prolonged therapy.

Q: Resistance to acyclovir is most commonly due to mutation in the viral gene that encodes a protein that:

Phosphorylates acyclovir. ### Explanation **Correct Option: B. Phosphorylates acyclovir** Acyclovir is a **nucleoside analog** that acts as a prodrug. To become active, it must undergo three phosphorylation steps. The first and most critical step is the conversion of acyclovir to acyclovir monophosphate, which is mediated by the viral enzyme **Thymidine Kinase (TK)**. Host cell enzymes then complete the conversion to acyclovir triphosphate, which inhibits viral DNA polymerase. The most common mechanism of resistance in Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV) is a **mutation in the viral gene encoding Thymidine Kinase**, resulting in a "TK-deficient" or "TK-altered" strain. Without this initial phosphorylation, the drug cannot be activated. **Analysis of Incorrect Options:** * **A. Converts viral RNA into DNA:** This describes Reverse Transcriptase (found in HIV). Acyclovir targets DNA viruses (HSV/VZV) and does not involve reverse transcription. * **C & D. Transport mechanisms:** Resistance to acyclovir is biochemical (enzymatic), not related to cellular influx or efflux pumps. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** Acyclovir triphosphate acts as a **chain terminator** because it lacks a 3' hydroxyl group, preventing further DNA elongation. * **Selectivity:** Acyclovir is highly selective because its initial phosphorylation occurs 100-1000 times faster in virus-infected cells than in uninfected cells. * **Cross-Resistance:** TK-deficient strains are also resistant to Valacyclovir and Famciclovir. * **Alternative for Resistance:** In cases of acyclovir resistance (common in immunocompromised patients), **Foscarnet** or **Cidofovir** are used because they do not require phosphorylation by viral Thymidine Kinase to be active.

Question 1

Which of the following statements about sulfonamides is FALSE?

Accepted Answer

Sulfonamides inhibit bacterial dihydropteroate synthase

Answer

Dysfunction of the basal ganglia may occur in the newborn if sulfonamides are administered late in pregnancy

Answer

Sulfonamide crystalluria is most likely to occur at low urinary pH

Answer

Sulfonamides are antimetabolites

Question 2

What is the recommended adult prophylaxis for meningococcal infection?

Accepted Answer

Rifampicin 600 mg twice daily for 2 days

Answer

Ampicillin 1 g daily for 5 days

Answer

Tetracycline 2 g daily for 1 day

Answer

Chloramphenicol 2 g daily for 2 days

Question 3

Cobicistat is used along with which of the following antiretroviral drugs?

Accepted Answer

Darunavir

Answer

Indinavir

Answer

Ritonavir

Answer

Saquinavir

Question 4

An inhibitor of bacterial protein synthesis with a narrow spectrum of antibacterial activity has been used in the management of abdominal abscess caused by Bacteroides fragilis, though antibiotic-associated colitis has occurred. Which of the following drugs is being described?

Accepted Answer

Clindamycin

Answer

Clarithromycin

Answer

Minocycline

Answer

Ticarcillin

Question 5

Which of the following is not an indication for cotrimoxazole?

Accepted Answer

Chancroid

Answer

Lower urinary tract infection (UTI)

Answer

Prostatitis

Answer

Typhoid fever

Question 6

Which of the following is not an established antimicrobial drug synergism at the clinical level?

Accepted Answer

Penicillin and tetracycline in bacterial meningitis

Answer

Amphotericin B and flucytosine in cryptococcal meningitis

Answer

Carbenicillin and gentamicin in pseudomonal infections

Answer

Trimethoprim and sulfamethoxazole in coliform infections

Question 7

A 75-year-old male develops a cough producing blood-tinged sputum and a fever of 104°F. A sputum smear reveals Gram-positive cocci in clusters, and a chest x-ray shows increased density in the right upper lobe. Which of the following penicillins is most likely to be ineffective against this patient's likely pathogen?

Accepted Answer

Ticarcillin

Answer

Oxacillin

Answer

Cloxacillin

Answer

Nafcillin

Question 8

Which antimalarial agent(s) should be avoided in pregnancy?

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Quinine

Answer

Anti-folates and Tetracyclines

Question 9

Which of the following antibiotics has the maximum auditory toxicity?

Accepted Answer

Amikacin

Answer

Streptomycin

Answer

Kanamycin

Answer

Tobramycin

Question 10

Resistance to acyclovir is most commonly due to mutation in the viral gene that encodes a protein that:

Accepted Answer

Phosphorylates acyclovir

Answer

Converts viral RNA into DNA

Answer

Transports acyclovir into the cell

Answer

Transports acyclovir out of the cell

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?